Combined neuroprotection and reperfusion therapy for stroke: Effect of lubeluzole and diaspirin cross-linked hemoglobin in experimental focal ischemia

Stroke

Volumn 27, Issue 9, 1996, Pages 1571-1577

  Aronowski, J ^a   Strong, R ^a   Grotta, J C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

cerebral ischemia, focal; neuroprotection; rats; reperfusion

Indexed keywords

BENZOTHIAZOLE DERIVATIVE; DIASPIRIN; HEMOGLOBIN DERIVATIVE; LUBELUZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COMMON CAROTID ARTERY; CONTROLLED STUDY; HEMODILUTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE;

EID: 0029794599     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.9.1571     Document Type: Article

References (24)

1. Merrill EW. Rheology of blood. Physiol Rev. 1969;49:863-888.
2. Hossmann KA, Van Den Kerckhoff W, Matsuoka Y. Treatment of cerebral ischemia by hemodilution. Bibl Haematol. 1981;47:77-85.
3. Grotta JC, Ackerman R, Correia J, Fallick G, Chang J. Whole blood viscosity parameters and cerebral blood flow. Stroke. 1982; 13:296-301.
4. Pereira BM, Weinstein PR, Rodriguez y Baena R. Effect of treatment of fluosol and mannitol during temporary middle cerebral artery occlusion in cat. Neurosurgery. 1988;23:139-143.
5. Cole DJ, Schell RM, Przybelski RJ, Drummond JC, Bradley K. Focal cerebral ischemia in rats: effect of hemodilution with α-α cross-linked hemoglobin on CBF. J Cereb Blood Flow Metab. 1992;12: 971-976.
6. α2). J Biol Chem. 1986;261:9929-9937.
7. Cole DJ, Schell RM, Drummond JC, Przybelski RJ, Marcantonio S. Focal cerebral ischemia in rats: effect of hemodilution with α-α cross-linked hemoglobin on brain injury and edema. Can J Neurol Sci. 1993;20:30-36.
8. Bowes MP, Burhop KE, Zivin JA. Diaspirin cross-linked hemoglobin improves neurological outcome following reversible but not irreversible CNS ischemia in rabbits. Stroke. 1994;25:2253-2257.
9. De Ryck M, Keersmaekers R, Clincke G, Janssen M, Van Reet S. Lubeluzole, a novel benzothiazole, protects neurologic function after cerebral thrombolytic stroke in rats: an apparent stereospecific effect. Soc Neurosci Abstr. 1994;20:185. Abstract.
10. Diener HC, Hacke W, Hennerici M, Radberg J, Hantson L, De Keyser J, for the Lubeluzole International Study Group. Lubeluzole in acute ischemic stroke: a double-blind, placebo-controlled phase II trial. Stroke. 1996;27:76-81.
11. De Ryck M, Scheller D, Clincke G, Janssen M, Van Reet S. Lubeluzole, a novel benzothiazole, protects neurologic function, reduces infarct size, and blocks peri-infarct glutamate rise after cerebral thrombotic stroke in rats. Cerebrovasc Res. 1995;5:264. Abstract.
12. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab. 1988;8:474-485.
13. Aronowski J, Samways E, Strong R, Grotta JC. A graded bioassay for demonstration of brain rescue from experimental acute ischemia. Stroke. 1994;25:2235-2240.
14. Zivin JA, Waud DR. Quantal bioassay and stroke. Stroke. 1992;23: 767-773.
15. Cechetto DF, Wilson JX, Smith KE, Wolski D, Silver MD, Hachinski C. Autonomic and myocardial changes in middle cerebral artery occlusion in the rat. Brain Res. 1989;502:296-305.
16. Butcher KS, Cechetto DF. Insular lesion evokes autonomic effect of stroke in normotensive and hypertensive rats. Stroke. 1995;26: 459-465.
17. Burns SM, Wyss JM. The involvement of the anterior cingulate cortex in blood pressure control. Brain Res. 1985;340:71-77.
18. National Institute of Neurology Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
19. Hossmann KA. Viability threshold and the penumbra of focal ischemia. Ann Neurol. 1994;36:557-565.
20. Ignarro LJ. Heat-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol Toxicol. 1990;67:1-7.
21. Schultz SC, Grady B, Cole F, Hamilton I, Burhop K, Malcolm DS. A role for endothelin and nitric oxide in the presser response to diaspirin cross-linked hemoglobin (DCLHb). J Lab Clin Med. 1993;122: 301-308.
22. Dawson VL, Dawson TM, Bartley DA, Uhl GR, Snyder SH. Mechanism of nitric oxide mediated neurotoxicity in primary brain cultures. J Neurosci. 1993;13:2651-2661.
23. Dalkara T, Yoshida T, Irikura K, Moskowitz MA. Dual role of nitric oxide in focal cerebral ischemia. Neuropharmacology. 1994;33: 1447-1452.
24. Gulati A, Rebello S. Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin. J Lab Clin Med. 1994; 124:125-133.